Estrogen Receptor–Positive (ER+), Premenopausal, Metastatic Breast Cancer Treatment Journey: Consideration of Ovarian Function Suppression (OFS) Drug Therapy

Download Resource

The Academy of Oncology Nurse & Patient Navigators, with support from TerSera Therapeutics, is delighted to offer you a resource to assist with educating your premenopausal patients with estrogen receptor-positive metastatic breast cancer and their caregivers as they navigate through the treatment journey, including managing the effects of ovarian function suppression drug therapy. Julie Justice Klunk, MSN, CRNP, OCN, CBCN, and Catherine Klein, RN, OCN, CBCN, advised on developing this patient pathway, included in this month’s Journal of Oncology Navigation & Survivorship issue.